Showing results (81-90 of 92) with videos related to

Sort By:
Pageof 10
The Journal of Clinical Endocrinology and Metabolism|November 5, 2002
Assessment of nondiagnostic ultrasound-guided fine needle aspirations of thyroid nodulesErik K Alexander, Jenny P Heering, Carol B Benson, et al.
Clinical Nephrology|December 10, 1999
The "point of no return" and the rate of progression in the natural history of IgA nephritisU Schöll, U Wastl, T Risler, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|April 23, 1999
Reduced incidence of acute renal graft failure in patients treated with peritoneal dialysis compared with hemodialysisR Vanholder, P Heering, A V Loo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 6, 2001
Gemcitabine and cisplatin in the treatment of advanced or metastatic pancreatic cancerV Heinemann, H Wilke, H G Mergenthaler, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 30, 2006
Long-term survival results of a randomized trial comparing gemcitabine/cisplatin and methotrexate/vinblastine/doxorubicin/cisplatin in patients with locally advanced and metastatic bladder cancerJ T Roberts, H von der Maase, L Sengeløv, et al.
Annals of Internal Medicine|February 15, 2003
Natural history of benign solid and cystic thyroid nodulesErik K Alexander, Shelley Hurwitz, Jenny P Heering, et al.
Anti-Cancer Drugs|November 26, 1999
Phase I trial of gemcitabine (Gemzar), 24 h infusion 5-fluorouracil and folinic acid in patients with inoperable pancreatic cancerH Oettle, U Pelzer, K Hochmuth, et al.
Kidney International|September 28, 2007
Cyclosporin in idiopathic glomerular disease associated with the nephrotic syndrome : workshop recommendationsD C Cattran, E Alexopoulos, P Heering, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 6, 2000
A phase II trial of gemcitabine in combination with 5-fluorouracil (24-hour) and folinic acid in patients with chemonaive advanced pancreatic cancerH Oettle, M Arning, U Pelzer, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 10, 2005
A phase III trial of pemetrexed plus gemcitabine versus gemcitabine in patients with unresectable or metastatic pancreatic cancerH Oettle, D Richards, R K Ramanathan, et al.
Pageof 10